← Evidence map

ArticleESMO open2024

The clinical dilemma of high-risk stage II colon cancer: are we truly prepared to withdraw oxaliplatin?

J Taieb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39626478